FTSE 100 finishes sharply lower as financial stocks weigh
FTSE 100, which has been hitting record highs over the past weeks, hit a five week low
Company
Scancell Holdings PLC
LON:SCLP
Scancell is a clinical stage biotech company developing immunotherapies for a cancer-free future by enhancing long-lasting tumour specific immunity. With deep roots in cancer immunology and translational research, the company aims to translate its innovation and creativity to address the need for fast, potent and accessible therapies that are easy to administer in hard-to-treat cancers.
329 stories · page 12 of 17
Archive
Proactive news snapshot: Ortac Resources, Strategic Minerals, Scancell Holdings…
A glance at some of the day's highlights from the Proactive Investors newswire
Bioquell jumps as says expects 2017 earnings to be "significantly" ahead of market expectations
A look at some of the top risers and fallers in London today
Scancell inks research collaboration deal with European biopharma BioNTech
The research collaboration will combine Scancell’s Moditope immunotherapy platform and BioNTech’s platform technology for high-throughput cloning and characterisation of naturally selected T cell receptors
FTSE 100 reaches new closing high with supermarkets in support
London's top tier index reached a new record high on Tuesday, led by supermarket shares
Archive
Proactive news snapshot: Synairgen, Iofina, Atlantis Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell soars as it confirms Cancer Research UK to fund and sponsor SCIB2 clinical trial
“We are delighted to announce this partnership with Cancer Research UK, which is a significant endorsement for our ImmunoBody technology”
Investments and investor services
Scancell Holdings soars after "stunning endorsement" of its ImmunoBody platform
Cancer Research UK was immensely impressed with the company and its technology
Archive
Proactive news snapshot: European Metals Holdings, Amphion Innovations, ImmuPharma
A glance at some of the day's highlights from the Proactive Investors newswire
FTSE 100 finishes a whisker from record high as BoE points to gradual rate hike
The FTSE 100 closed out Thursday up around 67 points at 7,555.
Rurelec shares more than double as power plant operator confirms takeover talks
A look at some of the biggest risers and fallers today in London
Archive
Proactive news snapshot: Strategic Minerals, MySQUAR, Haydale Graphene Industries …
A glance at some of the day's highlights from the Proactive Investors newswire
Conroy Gold rallies after being awarded all costs in court battle with dissident shareholder
A look at some of the top risers and fallers in London today
Scancell recruits deal maker to take over as CEO
Executive chairman John Chiplin said new CEO Dr Cliff Holloway's extensive experience and accomplishments speak volumes
FTSE 100 closes higher as Catalan president's speech in the spotlight
The UK benchmark finished the day at 7,538, up 30.38 points
Archive
Proactive news snapshot: Clinigen, Braveheart Investment, Alliance Pharma
A glance at some of the day's highlights from the Proactive Investors newswire
John Lewis of Hungerford serves up a treat for relieved investors
Some of the main news driven risers and fallers at 3.40pm…
Scancell on the lookout for partners after year of “significant progress”
“We are continuing to explore a number of funding options to ensure that we have the resources to progress these programmes through their next phase”
FTSE 100 closes 21 pts lower as miners weigh
The heavyweight dragged on the FTSE 100, which closed down 20.99 points